Related Experiment Video
Updated: Jul 11, 2026

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
Kinetic and biochemical characterization of Plasmodium falciparum GMP synthetase
Javaid Yousuf Bhat1, Brahmanaspati Ganapathi Shastri, Hemalatha Balaram
1Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bangalore-560064, India.
Abstract:
Plasmodium falciparum, the causative agent of the fatal form of malaria, synthesizes GMP primarily from IMP and, hence, needs active GMPS (GMP synthetase) for its survival. GMPS, a G-type amidotransferase, catalyses the amination of XMP to GMP with the reaction occurring in two domains, the GAT (glutamine amidotransferase) and ATPPase (ATP pyrophosphatase). The GAT domain hydrolyses glutamine to glutamate and ammonia, while the ATPPase domain catalyses the formation of the intermediate AMP-XMP from ATP and XMP. Co-ordination of activity across the two domains, achieved through channelling of ammonia from GAT to the effector domain, is the hallmark of amidotransferases. Our studies aimed at understanding the kinetic mechanism of PfGMPS (Plasmodium falciparum GMPS) indicated steady-state ordered binding of ATP followed by XMP to the ATPPase domain with glutamine binding in a random manner to the GAT domain. We attribute the irreversible, Ping Pong step seen in initial velocity kinetics to the release of glutamate before the attack of the adenyl-XMP intermediate by ammonia. Specific aspects of the overall kinetic mechanism of PfGMPS are different from that reported for the human and Escherichia coli enzymes. Unlike human GMPS, absence of tight co-ordination of activity across the two domains was evident in the parasite enzyme. Variations seen in the inhibition by nucleosides and nucleotide analogues between human GMPS and PfGMPS highlighted differences in ligand specificity that could serve as a basis for the design of specific inhibitors. The present study represents the first report on recombinant His-tagged GMPS from parasitic protozoa.
Insights
Plasmodium falciparum GMP synthetase (PfGMPS) survival is crucial for malaria. This study reveals unique kinetic mechanisms and domain coordination differences compared to human and E. coli enzymes, offering potential for targeted drug design.
Area of Science:
- Biochemistry
- Parasitology
- Enzymology
Background:
- Plasmodium falciparum causes severe malaria and requires GMP synthetase (GMPS) for survival.
- GMPS is a G-type amidotransferase with distinct glutamine amidotransferase (GAT) and ATP pyrophosphatase (ATPPase) domains.
Purpose of the Study:
- To elucidate the kinetic mechanism of Plasmodium falciparum GMP synthetase (PfGMPS).
- To compare the kinetic properties of PfGMPS with human and Escherichia coli GMPS.
- To identify potential targets for antimalarial drug development.
Main Methods:
- Kinetic analysis of recombinant His-tagged PfGMPS.
- Steady-state enzyme kinetics.
- Inhibition studies using nucleoside and nucleotide analogues.
Main Results:
- PfGMPS exhibits an ordered binding of ATP and XMP to the ATPPase domain, with random glutamine binding to the GAT domain.
- An irreversible Ping Pong step was observed, attributed to glutamate release preceding ammonia attack.
- PfGMPS shows less domain coordination than human GMPS, with distinct ligand specificities.
Conclusions:
- The kinetic mechanism of PfGMPS differs significantly from human and E. coli GMPS.
- Differences in domain coordination and ligand specificity present opportunities for designing specific PfGMPS inhibitors.
- This is the first report of recombinant His-tagged GMPS from a parasitic protozoan.
Related Concept Videos
Malaria
ATP Synthase: Mechanism
ATP Synthase: Structure

